Monalisa Mahapatra

Monalisa Mahapatra

Auto-generated profile, based on publicly available information

Monalisa Mahapatra

Medicinal Chemistry Research Laboratory School of Pharmaceutical Sciences Siksha ‘O’ Anusandhan Bhubaneswar Odisha 751003 India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
SMSuvadeep Mal
Suvadeep Mal
SCSubhasis Chakraborty
Subhasis Chakraborty
MMMonalisa Mahapatra
Monalisa Mahapatra
KPKakarla Pakeeraiah
Kakarla Pakeeraiah
SDSuvadra Das
Suvadra Das
PRPartha Roy
Partha Roy
From HAuCl4, nano-gold is synthesized via physical, chemical and green techniques. Systematic engineering with different functionalities shapes nano-gold into a sword with multimodal applicability against breast cancer, but what are the consequences?

1 October 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
KPKakarla Pakeeraiah
Kakarla Pakeeraiah
PSPragyan Paramita Swain
Pragyan Paramita Swain
ASAlaka Sahoo
Alaka Sahoo
PPPreetesh Kumar Panda
Preetesh Kumar Panda
MMMonalisa Mahapatra
Monalisa Mahapatra
SPSudhir Kumar Paidesetty
Sudhir Kumar Paidesetty
The briskened urge to develop potential antibacterial candidates against multidrug-resistant pathogens has motivated the present research study. Herein, newly synthesized coumarin derivatives with azomethine and amino-methylated as the functional groups have been focused on their antibacterial efficacy. The study proposed two distinct series: 3-acetyl substituted coumarin derivatives, followed by the Schiff base approach (5a–5i), and formaldehyde-secondary cyclic amine-based derivatives (7a–7g), using the Mannich base approach, further the compounds have been confirmed through various spectral studies. Further, target-specific binding affinity has been affirmed via in silico study. In vitro antibacterial study suggested compounds 5d and 5f to be most effective against S. aureus and multidrug-resistant K. pneumoniae, with MIC values of 8 and 16 μg mL−1. Among them, the compounds 5d and 5f showed excellent binding scores against different bacterial gyrase compared to the standard novobiocin. Based on RMRS, RMSF, Rg, and H-bond plots, MD simulation study at 100 ns also suggested better stability of 5d inside gyraseB of E. coli than the complex of E. coli-GyrB-novobiocin. The toxicity and pharmacokinetic profiles showed favorable drug-likeness. Overall, systematic in vitro and in silico assessment suggested that multimodal antibacterial derivatives 5d and 5f strongly inhibit both bacterial DNA gyrase and biofilm formation of drug-resistant pathogens, suggesting their potency in mainstream antibacterial therapy.

17 January 2025 in ChemistrySelect
Verified
Journal Article
Closed access
MMMonalisa Mahapatra
Monalisa Mahapatra
RDRohit Pritam Das
Rohit Pritam Das
KPKakarla Pakeeraiah
Kakarla Pakeeraiah
SMSuvadeep Mal
Suvadeep Mal
PPPreetesh Kumar Panda
Preetesh Kumar Panda
SPSudhir Kumar Paidesetty
Sudhir Kumar Paidesetty